Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-22-123224
Date:2022-11-29
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
Original Submission Date:

Reporting Person:

MCHUGH THOMAS S
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE DUBLIN 2, L2 D02 T380

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ADSS 2022-11-29 P 5,000 a $7.80 76,500 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the issuer's "adss" are american depositary shares, with each ads representing one ordinary share, nominal value $0.01 per share, of the issuer; adss may be represented by american depositary receipts.
WhaleWisdom Logo

Elevate your investments